NME1 and in situ carcinoma: There was a progressive down regulation of nm23 expression with neoplastic transformation; so that scores of 9 in non-proliferative breast disease decreased to 6 in carcinoma in-situ, to 3 in invasive cancer and 0 in meatstatic cancers.